Antigen Information
General Information of This Antigen
| Antigen ID | TAR0KPFBI |
|||||
|---|---|---|---|---|---|---|
| Antigen Name | CD70 antigen (CD70) |
|||||
| Gene Name | CD70 |
|||||
| Gene ID | ||||||
| Synonym | CD27L; CD27LG; TNFSF7; CD27 ligand;Tumor necrosis factor ligand superfamily member 7;CD_antigen=CD70 |
|||||
| Sequence |
MPEEGSGCSVRRRPYGCVLRAALVPLVAGLVICLVVCIQRFAQAQQQLPLESLGWDVAEL
QLNHTGPQQDPRLYWQGGPALGRSFLHGPELDKGQLRIHRDGIYMVHIQVTLAICSSTTA SRHHPTTLAVGICSPASRSISLLRLSFHQGCTIASQRLTPLARGDTLCTNLTGTLLPSRN TDETFFGVQWVRP Click to Show/Hide
|
|||||
| Family | Tumor necrosis factor family |
|||||
| Function |
Cytokine which is the ligand for CD27. The CD70-CD27 pathway plays an important role in the generation and maintenance of T cell immunity, in particular during antiviral responses. Upon CD27 binding, induces the proliferation of costimulated T-cells and enhances the generation of cytolytic T-cells.
Click to Show/Hide
|
|||||
| Uniprot Entry | ||||||
| HGNC ID | ||||||
| KEGG ID | ||||||
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
20000000
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
WO2024092067A1 ADC 2E7-LD003 (PA003) |
undisclosed |
Undisclosed |
Drug linker PB003 |
[1] | |
WO2024092067A1 ADC 2E7-LD004 (PA004) |
undisclosed |
Undisclosed |
Drug linker PB004 |
[1] | |
WO2024092067A1 ADC 2E7-LD008 (PA008) |
undisclosed |
Undisclosed |
Drug linker PB008 |
[1] | |
WO2024092067A1 ADC 2E7-LD038 (PA038) |
undisclosed |
Undisclosed |
Drug linker PB038 |
[1] | |
WO2024092067A1 ADC 2E7-LD039 (PA039) |
undisclosed |
Undisclosed |
Drug linker PB039 |
[1] | |
WO2024092067A1 ADC 2E7-LD040 (PA040) |
undisclosed |
Undisclosed |
Drug linker PB040 |
[1] | |
WO2024092067A1 ADC 2E7-LD082 (PA082) |
undisclosed |
Undisclosed |
Drug linker PB082 |
[1] | |
WO2024092067A1 ADC 2E7-LD083 (PA083) |
undisclosed |
Undisclosed |
Drug linker PB083 |
[1] | |
WO2024092067A1 2E7-deruxtecan |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly |
[1] | |
WO2024092067A1 2E7-vedotin |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[1] |
Anti-CD70
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
US12186310B2-35 |
Undisclosed |
Undisclosed |
Undisclosed |
[2] | |
US12186310B2-36 |
Undisclosed |
Undisclosed |
Undisclosed |
[2] | |
US12186310B2-37 |
Undisclosed |
Undisclosed |
Undisclosed |
[2] | |
US12186310B2-49 |
Undisclosed |
Undisclosed |
Undisclosed |
[2] |
Anti-CD70 (US12186310B2)
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
US12186310B2-10 |
Undisclosed |
Undisclosed |
Undisclosed |
[2] | |
US12186310B2-11 |
Undisclosed |
Undisclosed |
Undisclosed |
[2] |
Anti-CD70 antibody
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
PRO1160 |
Exatecan |
DNA topoisomerase 1 (TOP1) |
T1000 |
Anti-CD70 mAb
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
AMG 172 |
DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
||
Anti-CD70-45 ADC |
Tetrahydroisoquinoline-based PBD dimer 17 |
Human Deoxyribonucleic acid (hDNA) |
Mc-Val-Cit-PABC |
[3] | |
ARX305 |
Amberstatin 269 (AS269) |
Microtubule (MT) |
Oxime-PEG3 |
Anti-CD70 mAb 1F4
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Anti-CD70 mAb 1F4-IIIa-01 |
Anti-CD70 mAb 1F4-IIIa-01 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIa-01 linker |
[4] | |
Anti-CD70 mAb 1F4-IIIa-02 |
Anti-CD70 mAb 1F4-IIIa-02 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIa-02 linker |
[4] | |
Anti-CD70 mAb 1F4-IIIa-03 |
Anti-CD70 mAb 1F4-IIIa-03 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIa-03 linker |
[4] | |
Anti-CD70 mAb 1F4-IIIa-04 |
Anti-CD70 mAb 1F4-IIIa-04 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIa-04 linker |
[4] | |
Anti-CD70 mAb 1F4-IIIa-05 |
Anti-CD70 mAb 1F4-IIIa-05 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIa-05 linker |
[4] | |
Anti-CD70 mAb 1F4-IIIa-06 |
Anti-CD70 mAb 1F4-IIIa-06 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIa-06 linker |
[4] | |
Anti-CD70 mAb 1F4-IIIa-07 |
Anti-CD70 mAb 1F4-IIIa-07 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIa-07 linker |
[4] | |
Anti-CD70 mAb 1F4-IIIa-08 |
Anti-CD70 mAb 1F4-IIIa-08 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIa-08 linker |
[4] | |
Anti-CD70 mAb 1F4-IIIb-01 |
Anti-CD70 mAb 1F4-IIIb-01 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIb-01 linker |
[4] | |
Anti-CD70 mAb 1F4-IIIb-02 |
Anti-CD70 mAb 1F4-IIIb-02 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIb-02 linker |
[4] | |
Anti-CD70 mAb 1F4-IIIb-03 |
Anti-CD70 mAb 1F4-IIIb-03 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIb-03 linker |
[4] | |
Anti-CD70 mAb 1F4-IIIb-04 |
Anti-CD70 mAb 1F4-IIIb-04 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIb-04 linker |
[4] | |
Anti-CD70 mAb 1F4-IIIb-05 |
Anti-CD70 mAb 1F4-IIIb-05 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIb-05 linker |
[4] | |
Anti-CD70 mAb 1F4-IIIb-06 |
Anti-CD70 mAb 1F4-IIIb-06 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIb-06 linker |
[4] | |
Anti-CD70 mAb 1F4-IIIb-07 |
Anti-CD70 mAb 1F4-IIIb-07 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIb-07 linker |
[4] | |
Anti-CD70 mAb 1F4-IIIb-08 |
Anti-CD70 mAb 1F4-IIIb-08 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIb-08 linker |
[4] | |
Anti-CD70 mAb 1F4-IIIb-09 |
Anti-CD70 mAb 1F4-IIIb-09 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIb-09 linker |
[4] | |
Anti-CD70 mAb 1F4-IIIc-01 |
Anti-CD70 mAb 1F4-IIIc-01 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIc-01 linker |
[4] | |
Anti-CD70 mAb 1F4-IIIc-02 |
Anti-CD70 mAb 1F4-IIIc-02 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIc-02 linker |
[4] | |
Anti-CD70 mAb 1F4-IIIc-03 |
Anti-CD70 mAb 1F4-IIIc-03 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIc-03 linker |
[4] | |
Anti-CD70 mAb 1F4-IIIc-04 |
Anti-CD70 mAb 1F4-IIIc-04 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIc-04 linker |
[4] | |
Anti-CD70 mAb 1F4-IIIc-05 |
Anti-CD70 mAb 1F4-IIIc-05 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIc-05 linker |
[4] | |
Anti-CD70 mAb 1F4-IIIc-06 |
Anti-CD70 mAb 1F4-IIIc-06 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIc-06 linker |
[4] | |
Anti-CD70 mAb 1F4-IIIc-07 |
Anti-CD70 mAb 1F4-IIIc-07 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIc-07 linker |
[4] | |
Anti-CD70 mAb 1F4-IIIc-08 |
Anti-CD70 mAb 1F4-IIIc-08 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIc-08 linker |
[4] | |
Anti-CD70 mAb 1F4-A |
Anti-CD70 mAb 1F4-A payload |
Undisclosed |
Anti-CD70 mAb 1F4 linker |
[4] |
Anti-CD70 mAb 2H5
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Anti-CD70 ADC 12-2 |
Anti-CD70 ADC 12-2 payload |
Undisclosed |
Anti-CD70 ADC 12-2 linker |
[5] | |
Anti-CD70 ADC 2-7 |
Anti-CD70 ADC 2-7 payload |
Undisclosed |
Anti-CD70 ADC 2-7 linker |
[5] | |
Anti-CD70 ADC 3-4 |
Anti-CD70 ADC 3-4 payload |
Undisclosed |
Anti-CD70 ADC 3-4 linker |
[5] | |
Anti-CD70 ADC 4-3 |
Anti-CD70 ADC 4-3 payload |
Undisclosed |
Anti-CD70 ADC 4-3 linker |
[5] | |
Anti-CD70 ADC 5-3 |
Anti-CD70 ADC 5-3 payload |
Undisclosed |
Anti-CD70 ADC 5-3 linker |
[5] | |
Anti-CD70 ADC 6-2 |
Anti-CD70 ADC 6-2 payload |
Undisclosed |
Anti-CD70 ADC 6-2 linker |
[5] | |
Anti-CD70 ADC 7-1 |
Anti-CD70 ADC 7-1 payload |
Undisclosed |
Anti-CD70 ADC 7-1 linker |
[5] | |
Anti-CD70 ADC 8-5 |
Anti-CD70 ADC 8-5 payload |
Undisclosed |
Anti-CD70 ADC 8-5 linker |
[5] | |
Anti-CD70 ADC 9-4 |
Anti-CD70 ADC 9-4 payload |
Undisclosed |
Anti-CD70 ADC 9-4 linker |
[5] | |
Anti-CD70 ADC 10-1 |
Anti-CD70 ADC 10-1 payload |
Undisclosed |
Anti-CD70 ADC 10-1 linker |
[5] | |
Anti-CD70 ADC 11-5 |
Anti-CD70 ADC 11-5 payload |
Undisclosed |
Anti-CD70 ADC 11-5 linker |
[5] | |
Anti-CD70 ADC 12-3 |
Anti-CD70 ADC 12-3 payload |
Undisclosed |
Anti-CD70 ADC 12-3 linker |
[5] | |
Anti-CD70 ADC 13-7 |
Anti-CD70 ADC 13-7 payload |
Undisclosed |
Anti-CD70 ADC 13-7 linker |
[5] | |
Anti-CD70 ADC 14-5 |
Anti-CD70 ADC 14-5 payload |
Undisclosed |
Anti-CD70 ADC 14-5 linker |
[5] | |
Anti-CD70 ADC 15-5 |
Anti-CD70 ADC 15-5 payload |
Undisclosed |
Anti-CD70 ADC 15-5 linker |
[5] | |
Anti-CD70 ADC 16-5 |
Anti-CD70 ADC 16-5 payload |
Undisclosed |
Anti-CD70 ADC 16-5 linker |
[5] | |
Anti-CD70 ADC 17-2 |
Anti-CD70 ADC 17-2 payload |
Undisclosed |
Anti-CD70 ADC 17-2 linker |
[5] | |
Anti-CD70 ADC 18-3 |
Anti-CD70 ADC 18-3 payload |
Undisclosed |
Anti-CD70 ADC 18-3 linker |
[5] | |
Anti-CD70 ADC 19-5 |
Anti-CD70 ADC 19-5 payload |
Undisclosed |
Anti-CD70 ADC 19-5 linker |
[5] | |
Anti-CD70 ADC 20-5 |
Anti-CD70 ADC 20-5 payload |
Undisclosed |
Anti-CD70 ADC 20-5 linker |
[5] | |
Anti-CD70 ADC 21-5 |
Anti-CD70 ADC 21-5 payload |
Undisclosed |
Anti-CD70 ADC 21-5 linker |
[5] |
Anti-CD70 mAb c1F6
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
WO2007011968A2 c1F6-9a |
Monomethyl auristatin E |
Microtubule (MT) |
WO2007011968A2_c1F6-9a linker |
[6] | |
WO2007011968A2 c1F6-9b |
Monomethyl auristatin F |
Microtubule (MT) |
WO2007011968A2_c1F6-9b linker |
[6] | |
WO2007011968A2 c1F6-17 |
Doxorubicin |
DNA topoisomerase 2-alpha (TOP2A) |
WO2007011968A2_c1F6-17 linker |
[6] |
Anti-CD70 mAb h1F6
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
WO2015095755A1 h1F6-1.3 |
Monomethyl auristatin E |
Microtubule (MT) |
WO2015095755A1_h1F6-1.3 linker |
[7] | |
WO2015095755A1 h1F6-1006 |
WO2015095755A1_h1F6-1006 payload |
Undisclosed |
WO2015095755A1_h1F6-1006 linker |
[7] | |
WO2015095755A1 h1F6-2.0 |
Monomethyl auristatin E |
Microtubule (MT) |
WO2015095755A1_h1F6-2.0 linker |
[7] | |
WO2015095755A1 h1F6-5.6 |
WO2015095755A1_h1F6-5.6 payload |
Undisclosed |
WO2015095755A1_h1F6-5.6 linker |
[7] | |
WO2015095755A1 h1F6-6.4 |
WO2015095755A1_h1F6-6.4 payload |
Undisclosed |
WO2015095755A1_h1F6-6.4 linker |
[7] | |
WO2015095755A1 h1F6-7.7 |
WO2015095755A1_h1F6-7.7 payload |
Undisclosed |
WO2015095755A1_h1F6-7.7 linker |
[7] |
Anti-CD70 mAb humanized 1F6
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
h1F6-Compound 1 |
h1F6-compound 1 payload |
Undisclosed |
h1F6-compound 1 linker |
[8] | |
h1F6-Compound 2 |
h1F6-compound 2 payload |
Undisclosed |
h1F6-compound 2 linker |
[8] | |
h1F6-Compound 3 |
h1F6-compound 3 payload |
Undisclosed |
h1F6-compound 3 linker |
[8] |
Anti-CD70 mAb IF6
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
1F6-Val-Cit-PABC-MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Mal-Val-Cit-PABC |
[9] | |
1F6-Ile-Pro-AF |
Auristatin F |
Microtubule (MT) |
Mal-Ile-Pro |
[9] | |
1F6-Me3-Lys-Pro-AF |
Auristatin F |
Microtubule (MT) |
Mal-Me3Lys-Pro |
[9] | |
1F6-NorVal- (D)Asp-AF |
Auristatin F |
Microtubule (MT) |
Mal-NorVal-D-Asp |
[9] | |
1F6-beta-Ala- (D)Asp-AF |
Auristatin F |
Microtubule (MT) |
Mal-bata-Ala-D-Asp |
[9] | |
1F6-PhenylGly- (D)Lys-AF |
Auristatin F |
Microtubule (MT) |
Mal-PhenylGly-D-Lys |
[9] | |
1F6-Met- (D)Lys-AF |
Auristatin F |
Microtubule (MT) |
Mal-Met-D-Lys |
[9] | |
1F6-Asn- (D)Lys-AM |
Auristatin M |
Microtubule (MT) |
Mal-Asn-D-Lys |
[9] | |
1F6-Met- (D)Lys-AW |
L-Alanyl-L-tryptophan |
Microtubule (MT) |
Mal-Met-D-Lys |
[9] | |
1F6-Ile-Val-AF |
Auristatin F |
Microtubule (MT) |
Mal-Ile-Val |
[9] | |
1F6-Asp-Val-AF |
Auristatin F |
Microtubule (MT) |
Mal-Asp-Val |
[9] | |
1F6-His-Val-AF |
Auristatin F |
Microtubule (MT) |
Mal-His-Val |
[9] | |
1F6-Met-Lys-AF |
Auristatin F |
Microtubule (MT) |
Mal-Met-Lys |
[9] | |
1F6-Asn-Lys-AF |
Auristatin F |
Microtubule (MT) |
Mal-Asn-Lys |
[9] | |
1F6-Pro- (D)Lys-AF |
Auristatin F |
Microtubule (MT) |
Mal-Pro-D-Lys |
[9] | |
1F6-Met- (D)Lys-MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Mal-Met-D-Lys |
[9] | |
1F6-Asn- (D)Lys-MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Mal-Asn-D-Lys |
[9] | |
1F6-Met- (D)Lys-AM |
Auristatin M |
Microtubule (MT) |
Mal-Met-D-Lys |
[9] | |
1F6-Asn- (D)Lys-AW |
L-Alanyl-L-tryptophan |
Microtubule (MT) |
Mal-Asn-D-Lys |
[9] | |
1F6-Asn- (D)Lys-AF |
Auristatin F |
Microtubule (MT) |
Mal-Asn-D-Lys |
[9] |
Anti-CD70 mAb murine 1F6
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
m1F6-Compound 1 |
m1F6-compound 1 payload |
Undisclosed |
m1F6-compound 1 linker |
[8] | |
m1F6-Compound 2 |
m1F6-compound 2 payload |
Undisclosed |
m1F6-compound 2 linker |
[8] | |
m1F6-Compound 3 |
m1F6-compound 3 payload |
Undisclosed |
m1F6-compound 3 linker |
[8] |
Chimeric Anti-CD70 Anti-ody
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Alpha-CD70-Mc-MMAF |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[10] |
h1F6
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
TW201803600A ADC-6 |
PBD |
Undisclosed |
Undisclosed |
[11] |
H1F6ec
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
SGN-CD70A |
PBD dimer |
Human deoxyribonucleic acid (hDNA) |
dipeptide linker |
Humanized anti-CD70 mAb
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
ARX-305 |
Monomethyl auristatin F |
Microtubule (MT) |
Oxime-PEG3 |
MDX-1115
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
BMS-936561 |
Seco-MED-A |
Human deoxyribonucleic acid (hDNA) |
Mal-Val-Cit |
Vorsetuzumab
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Vorsetuzumab mafodotin |
MMAF |
Microtubule (MT) |
Maleimido-caproyl |
||
CD70-MMAF-ADC |
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
[12] |
Undisclosed
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Anti-CD70 antibody-drug conjugate (XDCExplorer) |
Undisclosed |
Undisclosed |
Undisclosed |
[13] | |
CD70-glucocorticoid ADC |
Fluticasone propionate |
Glucocorticoid receptor (NR3C1) |
Pyrophosphate linker |
[14] |
undisclosed
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
CN105899515B III |
Undisclosed |
Undisclosed |
Undisclosed |
[15] |
References
